NCPDP to explore VBAs for prescription drugs at its virtual education summit, November 15-16, 2021


Event showcasing the drivers of value-based arrangements for prescription drugs and presenting the perspectives of multiple stakeholders on the current state of AVB, the challenges, opportunities and standards that support them VBA.

SCOTTSDALE, Arizona., November 5, 2021 / PRNewswire-PRWeb / – The NCPDP has announced its 2021 Educational Summit on Value-Based Arrangements (VBAs) for Prescription Drugs, a virtual event to be held from 11:004 p.m. EST to November 15 and 16, 2021. VBAs for prescription drugs are largely untapped opportunities to improve patient experience, health outcomes and value-based care cost savings, providing a way to reinvent reimbursement and to track, monitor and measure the critical point between diagnosis and patient health outcomes. The 2021 NCPDP Education Summit will present an engaging and informative overview of VBAs, with a variety of healthcare players sharing their knowledge, experiences and perspectives on the challenges and opportunities of VBAs, as well as the standards currently available. to support them.

Each day of the NCPDP Education Summit will begin with a panel discussion chaired by Sloane Salzburg, Vice President of the Council for Affordable Health Coverage, followed by in-depth presentations. At Monday November 15th, panelists from government and payers will discuss the drivers of VBAs. The round table on Tuesday November 16, will focus on the perspectives of suppliers, pharmacies and suppliers. The final session of the Educational Summit will recap current industry standards that support VBAs and a summary of new transactions or standards that the NCPDP can pursue in conjunction with its strategic goals for VBAs. The moderator of the program will be Kim diehl boyd, Vice-President, Industrial Relations and Government Affairs, CoverMyMeds.

Confirmed speakers:

  • Sloane Salzburg, Vice President, Council for Affordable Health Coverage – Sloane specializes in health policies related to Medicare Part D, medication adherence, drug pricing, precision medicine and general reform health, as well as building alliances with third parties and managing coalitions. Within CASC, Sloane is executive director of the Campaign for Transformative Therapies, which aims to develop and advocate for policies that encourage value-based payment terms for gene therapies. She is also vice president of Horizon Government Affairs, a Washington-based health policy consultancy.

  • John M. Coster, Director, Pharmacy Division at the Center for Medicaid and CHIP Services, CMS – John M. Coster is director of the pharmacy division at the Center for Medicaid and CHIP Services, which is a component of the Centers for Medicare and Medicaid Services. He is responsible for policy and operational matters relating to the Medicaid Pharmacy Program and the Medicaid Drug Rebate Program (MDRP). He holds an MPS and a doctorate. in the health policy of the University of Maryland Higher School of Baltimore and a BS in pharmacy from Saint-Jean University in new York. Prior to joining CMS, he held senior government affairs positions with the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), and Safety Net Hospitals for Pharmaceutical Access.

  • Peter W. McCauley Sr., MD, CPE, Chief Medical Officer, Cigna HealthCare – In his current role as Chief Medical Officer for Cigna Health Care, Peter W. McCauley Sr., MD has national responsibility for Cigna’s more than 400 value-based relationships. This includes more than 250 Cigna Collaborative Accountable Care (ACO) agreements serving more than 3 million Cigna customers across United States. Dr. McCauley and his teams work directly with large groups of physicians and hospital systems to build and maintain relationships that ensure Cigna clients receive the highest quality health care services at the most reasonable cost. Dr. McCauley continues to practice pediatrics at the Altgeld Clinic on that of Chicago the far south where he volunteered for over 23 years.

  • Tony rodgers, MSPH, CEO, VBCare – Tony rodgers is an experienced healthcare executive who has held leadership positions in both the public and private sectors, including federal and state agencies, private health plans and hospital systems. His past leadership experience includes CMS Deputy Administrator, Center for Strategic Planning (CSP), where he oversaw CMS Medicare demonstrations and the CMS community health database. While at CMS, he also collaborated on many CMS Innovation Center alternative payment models and delivery system reform initiatives. He is currently the Managing Director of VBCare Network LLC and ABC Network LLC, which are value-based provider networks serving Medicaid and Medicare beneficiaries in Arizona.

  • Ben shirley, CPHQ, Director, Performance Measurement, Alliance pour la qualité en pharmacy (PQA) – Ben shirley is Director of Performance Measurement at the Pharmacy Quality Alliance (PQA). He draws on a background in health policy and several years of experience in quality measurement to provide PQA with expertise in several phases of the measurement development process, including specification, analysis, approval. and maintenance. He plays a key role in the execution of PQA’s pharmacy measurement strategy, including leading groups of measurement-specific technical experts and developing pilot projects that incorporate innovative metrics into contracts based on the pharmacy-payer value. Prior to joining the PQA team, Ben worked as an Insurance and Value-Based Care Analyst at IMPAQ Health, where he supported hospital quality measurement development contracts and funded health plans. CMS in the areas of care coordination and patient safety.

  • Nate brat, Vice-President, Product Strategy, Ontario | McKesson Corporation – Nate brat is the Vice President of Product Strategy for Ontario. He leads portfolio and partner strategy with the goal of driving customer growth and success for specialist vendor technology as well as oncology knowledge and expert services. Nate joined McKesson in 2011 and most recently served as Vice President of Product Strategy for the Specialty Provider Solutions business. Previously, Nate was a consultant for McKinsey and Company and a biomedical researcher at University of California, San Francisco. Nate has driven the adoption of value-based arrangements – for commercial and government programs – in specialty care through multiple channels: launching vendor technology and reporting tools, establishing pathway programs collaborative pay-provider clinics and premier partnership relationships to link meaningful clinical data between providers. and paying intermediaries.

  • Justin heiser, PharmD, Executive Vice President of Pharmaceutical Operations, Thrifty White Pharmacy – Justin heiser, PharmD is Executive Vice President of Pharmaceutical Operations at Thrifty White Pharmacy. Since joining the pharmacy chain owned by 100 store employees in 2007, he has held several positions within the company focused on strategy, business development, strategic partnerships as well as technology development. exclusive that integrates data-driven, value-based care programs into the pharmacy workflow.

  • Heather gibson, Associate Director, Performance Measurement, Pharmacy Quality Alliance (PQA) – Heather gibson Acts as Associate Director of Performance Measurement for the Pharmacy Quality Alliance (PQA), providing expertise in several phases of the measurement development process. She supports PQA in executing its pharmacy measurement strategy, including leading technical expert groups and providing feedback on pilot projects that incorporate innovative metrics into value-based contracts from pharmacists and pharmacists. payers. Heather also played a key role in a recent series of PQA-led summits, which brought together multi-stakeholder opinion leaders to identify and prioritize pharmacy measurement concepts that could be used in payment-based agreements. pharmacy payor value. Heather previously worked at HSAG as a Health Services Researcher, where she supported the development of quality metrics for CMS funded health plans in the area of ​​patient safety.

  • JW Hill, MBAHCM, CNED, Executive Vice President and General Manager, NCPDP – John oversees and is responsible for all day-to-day activities of the organization and leads the leadership team to achieve financial goals and operational performance; and provides strategic support to the President and CEO of the NCPDP. He drives the goal of the NCPDP’s three-year ABV plan: NCPDP will be recognized for ensuring that value-based healthcare models can meet the goal of improving patient health outcomes.

Pharmacists and pharmacy technicians can accumulate hours of continuing education in pharmacy (CPE) with the ACPE.

The NCPDP Educational Summit is open to members and non-members. Register before Sunday November 14, to take advantage of the extended Early Bird rate $ 475. To register for the 2021 NCPDP Educational Summit on Value-Based Arrangements for Prescription Drugs, visit

Founded in 1977, NCPDP is an ANSI-accredited, not-for-profit standards development organization with more than 1,500 members representing virtually all sectors of the pharmaceutical service industry. Our diverse members deliver leadership and healthcare solutions through education and standards, created through the consensus building process. NCPDP has been named in federal legislation including HIPAA, MMA, and HITECH. NCPDP members have created standards such as Telecommunications Standard and Batch Standard, SCRIPT Standard for Electronic Prescribing, Manufacturers Discount Standard and more to improve communication within the pharmaceutical industry. Our data products include dataQ®, a strong database of information on more than 80,000 pharmacies, resQ ™, an accreditation resource for industry pharmacies, and HCIdea®, an innovative prescriber database that provides continuously updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of national and national pharmacy-related legislative and regulatory activities. For more information on NCPDP standards, data services, products, educational programs and working group meetings, go online at or call 480.477.1000 .


Media contact

Janet Cabibbo, NCPDP, 480-477-1000 x 104,

Maggie Bruce, NCPDP, 480-477-1000 x144,



[ad_2]Source link

About Alex S. Crone

Check Also

Now is not the time for the CDC to relax opioid prescribing guidelines

[ad_1] Contact: Communications Office 850-245-4111 This month, the Centers for Disease Control and Prevention …

Leave a Reply

Your email address will not be published.